Cutera Announces International Commercial Launch of AviClear for the Treatment of Acne

Cutera Announces International Commercial Launch of AviClear for the Treatment of Acne image

Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, and Australia. Select practices will begin training on the technology in the coming weeks.

AviClear is a 1726nm laser, which targets and suppresses the production of sebum, thereby treating acne at its source.[1-3] AviClear delivers high power (100W) selectively to the sebaceous glands, the source of sebum production, while protecting surrounding tissue through Cutera’s AviCool contact cooling technology.[3,4] In a clinical trial, 92% of patients were deemed responders to the therapy (resolution of at least half of their acne), with a 79% median reduction in inflammatory lesion count, at the 12-month mark following the final treatment.[1]

At the International Master Course on Aging Science (IMCAS) conference in Paris, February 1-3, David J. Goldberg, MD, JD, presented results of 75 patients treated in his practice with AviClear following the FDA clearance in March 2022. The data demonstrated similar efficacy results, in a real-world environment, as seen in the pivotal study, and highlighted the durability of AviClear’s treatment, with some patients reaching 18 months of follow-up.[5]

Cutera will commence a steady rollout of AviClear across the UK and EU in 2024. Interested providers can visit for more information.


1 Data on file. FDA clearance study. Cutera Inc.

2 O’Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome. 2018;6:177.

3 Sakamoto FH, et al. Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser. Lasers Surg Med. 2012;44(2):175-183.

4 Scopelliti MG, et al. Selective photothermolysis in acne treatment: The impact of laser power. J Cosmet Dermatol. 2023;00:1.7. Manuscript in press.

5 Data on file. David J. Goldberg, MD, JD

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free